Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (13)
P 1 (1)
P 2 (4)
P 4 (1)

Trial Status

Recruiting11
Not Yet Recruiting6
Completed3
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT07563868Not ApplicableRecruitingPrimary

Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression

NCT07080723Phase 4RecruitingPrimary

Algorithm Guided Treatment Versus Treatment as Usual (TAU) for Patients With Treatment Resistant Depression

NCT07247006Phase 2Not Yet RecruitingPrimary

Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression

NCT07146503Recruiting

Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression

NCT07376018Not ApplicableNot Yet Recruiting

Ketogenic Diet and Neuromodulation in Treatment Resistant Depression

NCT07329153Not ApplicableNot Yet RecruitingPrimary

Neuronavigated aiTBS for TRD

NCT07217223Not ApplicableRecruitingPrimary

Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study

NCT07324070Not ApplicableRecruiting

Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression

NCT07307768Phase 1Not Yet RecruitingPrimary

Ketamine Biomarker Validation

NCT07287839Phase 2Not Yet RecruitingPrimary

Parcel-guided rTMS for Major Depressive Disorder

NCT06773949Not ApplicableRecruiting

Feasibility Trial of Exercise as a Priming Strategy for rTMS Treatment in Difficult-to-Treat Depression

NCT07264452Not ApplicableRecruitingPrimary

Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst Stimulation in Patients With Treatment-Resistant Depression

NCT06668571Phase 2Recruiting

Intravenous Ketamine for Treatment-Resistant Depression

NCT07097025CompletedPrimary

2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Recommendation

NCT06783361Not ApplicableActive Not RecruitingPrimary

Accelerated Transcranial Magnetic Stimulation in Treatment-Resistant Depressed Patients

NCT05952674Not ApplicableRecruitingPrimary

Treatment Resistant Depression and Vagus Nerve Stimulation

NCT06682299Not ApplicableRecruitingPrimary

Maintenance TMS in Treatment Resistant Depression

NCT06881030Not ApplicableNot Yet RecruitingPrimary

Comparison of Different Acceleration Modes of Transcranial Magnetic Stimulation

NCT06812923Not ApplicableRecruitingPrimary

TACS on High-inflammatory and Refractory Depression

NCT06729580Not ApplicableCompletedPrimary

Risk-Targeted Behavioural Activation for the Management of Treatment-Resistant Depression.

Scroll to load more

Research Network

Activity Timeline